FDA issued a Warning Letter to Vista Pharmaceuticals Limited on 7/5/2017 as a result of this inspection.
483 Vista Pharmaceuticals Sep 2016

483 Vista Pharmaceuticals Sep 2016

Dennis Cantellops Paite FDA, Deyaa Shaheen FDA$119.00 - Available Now

FDA investigators audited the Vista Pharmaceuticals - Nalgonda District, India facility and issued inspectional observations (via FDA 483) on 23 Sep 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Sep 2016
  • Location: Nalgonda District, India
  • FEI: 3003978209
Add To Cart